Picture of the Week and Clinical Case Presentations: CCBD Management Rounds

  • To apply the principles of evidence-based medicine in the diagnosis and work-up of children with hematological and oncological diseases
  • To design and apply a treatment plan for patients with hematological and oncological diseases
  • To evaluate and manage the treatment and potential complications patients with complex hematological and oncological disorders experience

EBM: Basics of Gene Therapy for Sickle Cell Disease

  • Participants will be able to counsel patients on the two FDA approved gene editing therapies for sickle cell disease
  • Participants will be able to identify and manage complications of stem cell collection
  • Learning can apply current clinical guideline to determine the most appropriate curative treatment options for individuals with sickle cell disease, considering eligibility criteria, risks, and benefits.

 

Session date: 
11/20/2025 - 1:00pm to 3:00pm EST
Location: 
Children's National Hospital
111 Michigan Avenue NW
Washington, DC 20010
United States
See map: Google Maps
Add to calendar: 
  • 2.00 AMA PRA Category 1 Credit™
    Children’s National Hospital designates this Live activity for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 2.00 ANCC
    Children’s National Hospital will provide 2.00 Nursing Contact Hours for this Live activity.
  • 2.00 Participation
    Successful completion of this continuing education activity.
Please login or register to take this course.
Faculty List: 
Course Director(s)

Liny John, MD

has no relevant financial relationships to disclose at this time.

Birte Wistinghausen, MD

has no relevant financial relationships to disclose at this time.
Speaker(s)

Mizna Ahmad, MD

has no relevant financial relationships to disclose at this time.